|
GLMD Galmed Pharmaceuticals Ltd 1595353 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-2,723,000.00 |
| Balance Sheet |
|
Current Assets
|
$11,713,000.00 |
|
Assets
|
$18,283,000.00 |
|
Current Liabilities
|
$2,814,000.00 |
|
Equity
|
$12,738,000.00 |
|
Shares Out
|
1001394.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,663,000.00 |
|
Investing Cash Flow
|
$2,395,000.00 |
| Market Analysis |
Market Cap
|
$4,566,356.64 |
|
Price
|
$4.56 |
|
BVPS
|
12.72 |
|
PB
|
0.36 |
|
EPS
|
2.86 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:03 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GLMD documents filed with the SEC.
GLMD Filings
Clear
